Biotechnology Instruments Market 2021 Size Worth US$ 206.7 Bn By 2030


The global biotechnology instruments market size is expected to be worth around US$ 206.7 billion by 2030, according to a new report by Vision Research Reports.

The global biotechnology instruments market size was valued at US$ 45.14 billion in 2020 and is anticipated to grow at a CAGR of 20.60% during forecast period 2021 to 2030.

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@

Biotechnology Instruments Market (By Product: Lab Automation Instruments, Life Science Consumables, IVD Instruments, Medical Lasers; By End-use: Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Report Coverage

Report Scope Details
Market Size USD 206.7 billion by 2030
Growth Rate CAGR of 20.60% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Abbott; Agilent Technologies; Alcon, Inc.; AngioDynamics; Becton, Dickinson, and Company; BioMerieux SA; Bio-Rad Laboratories; BioTek Instruments, Inc.; Candela Medical; Cynosure, LLC; Danaher Corporation; Endress+Hauser (Analytik Jena GmbH); F. Hoffmann-La Roche Ltd.; IIlumina Inc.; IRIDEX; Lumenis; Merck KGaA; Novanta,  Inc.; Perkin Elmer, Inc.; QIAGEN

Growth Factors

  The growth in the biotechnology industry can also be attributed to several factors such as the launch of new and innovative products, agreements, acquisitions, technological advancements, and increasing adoption in various applications. Rising demand for POC devices in the home and other healthcare settings to cater to the elderly population and increasing government initiatives to shorten hospital stays by establishing outpatient care models are expected to drive the demand for POC diagnostics over the next six years.

Report Highlights

The life science consumables segment dominated the market in 2020 with a revenue share of over 65.0% and is expected to grow at the fastest rate over the forecast period. The launch of new PCR test kits is expected to be a major driver for the segment. Medical lasers have emerged as a lucrative market space, primarily due to their expanding applications. Medical lasers have been used predominantly in various surgical procedures.

Hospitals and healthcare facilities accounted for the largest revenue share of over 55.0% in 2020. COVID-19 has fueled the demand for IVD point-of-care devices in hospitals. Recent advancements in IVD instruments have made them convenient to use and highly efficient, which has raised their adoption across healthcare settings.

North America captured the largest revenue share of over 50.0% in 2020 owing to the high demand and affordability of biotechnology instrumentation. In addition, the inclination toward manual automation in the biotechnology, pharmaceuticals, and related industries in the region is boosting the demand for advanced and sophisticated instruments to ease and accelerate the process.

The COVID-19 pandemic has created a need for rapid diagnostic assays and self-testing kits, and several companies are actively fulfilling these requirements. In December 2020, Shimadzu Corporation launched fully automated PCR testing AutoAmp Genetic Analyzer (AutoAmp) in Japan. This enhanced the COVID-19 testing capabilities of clinics in Japan.

Key Players

  • Abbott
  • Agilent Technologies
  • Alcon, Inc.
  • AngioDynamics
  • Becton, Dickinson, and Company
  • BioMerieux SA
  • Bio-Rad Laboratories
  • BioTek Instruments, Inc.
  • Candela Medical
  • Cynosure, LLC
  • Danaher Corporation
  • Endress+Hauser (Analytik Jena GmbH)
  • F. Hoffmann-La Roche Ltd.
  • IIlumina Inc.
  • Lumenis
  • Merck KGaA
  • Novanta, Inc.
  • Perkin Elmer, Inc.
  • Siemens  Healthineers
  • Tecan Group AG
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation
  • Zimmer MedizinSysteme

Market Segmentation

  • Product
    • Lab Automation Instruments
      • Proteomics
      • Genomics
      • Sequencing
      • Spatial Cell Analysis
      • Others
    • Life Science Consumables
    • IVD Instruments
    • Medical Lasers
      • Therapeutics
      • Ophthalmic
      • Ablation
  • End-use
    • Government & Academic Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Healthcare Facilities
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa
      • Saudi Arabia

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Buy This Premium Research Report, click here@ or call: +1 9197 992 333


Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published.